跳至主要内容
临床试验/NCT01249066
NCT01249066Unknown不适用

Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1

研究概览

简要总结

AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves as an energy guardian to help cells adapt to various metabolic stress including hypoxia. Because the role of AMPK in cancers has not been fully elucidated, in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
25 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Lung cancer received operation lobectomy in CMUH

排除标准

  • History of uremia, other malignant disease, and liver cirrhosis
  • History of pneumonia and pulmonary tuberculosis
  • History of long period of medications.

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验